Professor of Otolaryngology, University Pittsburgh
Otolaryngology (ENT)
Dr. Jonas T. Johnson, MD
|
|
Give Review
Jonas T. Johnson works in the field of Otolaryngology (ENT). He studied medicine at SUNY Upstate Medical University. He received 6 awards: "America's Top Doctors", "America's Top Doctors for Cancer", "Pittsburgh Magazine", "Fellow (FAAO-HNS)", "Fellow (FACS)" and "Top MD". Doctor Jonas T. Johnson, MD is a published doctor. He has 89 papers published. The most current publication "Utility of a perioperative nutritional intervention on postoperative outcomes in high-risk head & neck cancer patients." Dr. Jonas T. Johnson accepts Medicare.
Publications
- Utility of a perioperative nutritional intervention on postoperative outcomes in high-risk head & neck Cancer patients.
- Incidence, outcome, and risk factors for postoperative pulmonary complications in head and neck Cancer surgery patients with free flap reconstructions.
- An enhanced role for palliative care in the multidisciplinary approach to high-risk head and neck Cancer.
- A prospective phase 2 trial of reirradiation with stereotactic body radiation therapy plus cetuximab in patients with previously irradiated recurrent squamous cell car...
- PectOralis major myofascial onlay and myocutaneous flaps and pharyngocutaneous fistula in salvage laryngectomy.
- Adjuvant stereotactic body radiotherapy ± cetuximab following salvage surgery in previously irradiated head and neck Cancer.
- Is level V neck dissection necessary in primary parotid Cancer?
- Factors contributing to recurrence of oral cavity and Laryngeal tumors and estimation of tumor age.
- What is the perioperative antibiotic prophylaxis in adult oncologic Head and neck surgery?
- Posttraumatic stress disorder (PTSD) symptoms in newly diagnosed head and neck Cancer patients and their partners.
- Occult Primary Head and Neck Squamous Cell Carcinoma: Utility of Discovering Primary Lesions.
- Erlotinib, erlotinib-sulindac vs. placebo: a randomized, double-blind, placebo-controlled window trial in operable head and neck Cancer.
- Frailty Measurements and Dysphagia in the Outpatient Setting.
- TransOral Robotic Surgery and the Unknown Primary: A Cost-Effectiveness Analysis.
- Effect of weight loss on short-term outcomes and costs of care after head and neck Cancer surgery.
- Clinical outcome of patients with carcinoma ex pleomorphic adenoma of the parotid Gland: A comparative study from a single tertiary center.
- PET/CT in Head and neck oncology: State-of-the-art 2013.
- Teaching the TeAcher: An Essential Obligation Presidential Address.
- Effects of adjuvant chemoradiotherapy on the frequency and function of regulatory T cells in patients with head and neck Cancer.
- Dysphagia: perspectives on an old problem: the hayes martin lecture, 2013.
- Quality of life in head and neck Cancer patients: Impact of HPV and primary treatment modality.
- Human Papillomavirus-Associated Adenocarcinoma of the Base of Tongue: Potentially Actionable Genetic Changes.
- Clinical significance of intra-parotid lymph node metastasis in primary parotid Cancer.
- Accuracy of Computed Tomography in the Prediction of Extracapsular Spread of Lymph Node Metastases in Squamous Cell Carcinoma of the Head and Neck.
- Early squamous cell carcinoma of the Oral tongue: Comparing margins obtained from the glossectomy specimen to margins from the tumor bed.
- A multi-institutional investigation of the prognostic value of lymph nodal yield in advanced stage Oral cavity squamous cell carcinoma (OCSCC).
- Frequent Mutation of the PI3K Pathway in Head and Neck Cancer Defines Predictive Biomarkers.
- Extracapsular spread in Head and neck carcinoma: Impact of site and human papillomavirus status.
- RAS Mutations in Thyroid FNA Specimens Are Highly Predictive of Predominantly Low-Risk Follicular-Pattern Cancers.
- Negative Predictive Value of Surveillance PET/CT in Head and Neck Squamous Cell Cancer.
- Ewing Sarcoma of the thyroid: Report of 2 cases and review of the literature.
- The Immune Signature of CD8+CCR7+ T Cells in the Peripheral Circulation Associates with Disease Recurrence in Patients with HNSCC.
- A new paradigm for the diagnosis and management of unknown primary tumors of the Head and neck: a role for transoral robotic surgery.
- Histological assessment of cervical lymph node identifies patients with Head and neck squamous cell carcinoma (HNSCC) who would benefit from chemoradiation after surgery.
- A cost-effectiveness analysis of positron emission tomography-computed tomography surveillance versus up-front Neck dissection for management of the Neck for N2 diseas...
- Screening for head and neck Cancer in liver transplant candidates: A review of 11 years of experience at the University of Pittsburgh.
- The physician as team leader: new job skills are required.
- Parotid Tumor size predicts proximity to the facial nerve.
- Management of the "Violated Neck" in the era of chemoradiation.
- The laryngoscope gets a new editor.
- Impact of Mutational Testing on the Diagnosis and Management of Patients with Cytologically Indeterminate Thyroid Nodules: A Prospective Analysis of 1056 FNA Samples.
- A combined molecular-pathologic score improves risk stratification of Thyroid papillary microcarcinoma.
- Development of consensus guidelines for venous thromboembolism prophylaxis in patients undergoing microvascular reconstruction of the mandible.
- The ethics of medical publication.
- The cost-effectiveness of community-based screening for oral Cancer in high-risk males in the United States: a Markov decision analysis approach.
- Antibiotic prophylaxis in uncontaminated Neck dissection.
- Prognostic factors in patients with high-risk locally advanced salivary gland Cancers treated with surgery and postoperative radiotherapy.
- Clinicopathologic features as stronger prognostic factors than histology or grade in risk stratification of primary parotid malignancies.
- The utility of fine needle aspiration to identify unusual pathology in a parapharyngeal mass.
- Induction docetaxel, cisplatin, and cetuximab followed by concurrent radiOtherapy, cisplatin, and cetuximab and maintenance cetuximab in patients with locally advanced...
- Publication misrepresentation among otolaryngology residency applicants.
- Adenosine and prostaGlandin E2 cooperate in the suppression of immune responses mediated by adaptive regulatory T cells.
- Treatment of postsurgical pyoderma gangrenosum with a high-potency topical steroid.
- Polymorphous low-grade adenocarcinoma: the University of Pittsburgh experience.
- Management of patients treated with chemoradiotherapy for head and neck Cancer without prophylactic feeding tubes: the University of Pittsburgh experience.
- Incidence and patterns of regional metastasis in early oral squamous cell Cancers: feasibility of submandibular gland preservation.
- Evidence in medicine.
- Stereotactic body radiotherapy for recurrent squamous cell carcinoma of the Head and neck: results of a phase I dose-escalation trial.
- A contemporary review of indications for primary surgical care of patients with squamous cell carcinoma of the Head and neck.
- Brief history of the Triological Society and The Laryngoscope.
- What's new in the laryngoscope.
- Management of squamous cell carcinoma of the base of Tongue with chemoradiation and brachytherapy.
- Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck Cancer.
- Intratumoral epidermal growth factor receptor antisense DNA therapy in head and neck Cancer: first human application and potential antitumor mechanisms.
- Ethical medical reporting.
- Ocular outcomes after gold weight placement and facial nerve resection.
- Role of surgery in limited (T1-2, N0-1) Cancers of the oropharynx.
- Papillary thyroid Cancer: controversies in the management of neck metastasis.
- Treatment and survival outcomes based on histologic grading in patients with Head and neck mucoepidermoid carcinoma.
- Two sites of Head and neck squamous cell carcinoma: utility of loss of heterozygosity.
- T regulatory type 1 cells in squamous cell carcinoma of the head and neck: mechanisms of suppression and expansion in advanced Disease.
- Long-term results of a phase III randomized trial of postoperative radiotherapy with or without carboplatin in patients with high-risk head and neck Cancer.
- Indications for PET/CT in the Head and neck.
- Reduction of snoring with a plasma-mediated radiofrequency-based ablation (Coblation) device.
- Deferring planned neck dissection following chemoradiation for stage IV head and neck Cancer: the utility of PET-CT.
- The frequency and suppressor function of CD4+CD25highFoxp3+ T cells in the circulation of patients with squamous cell carcinoma of the Head and neck.
- A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the Tumor microenvironment.
- European surgeons were the first to perform Neck dissection.
- Standards for ethical publication.
- Challenges we must confront.
- Selective neck dissection in patients with upper aerodigestive tract Cancer with clinically positive nodal disease.
- Cervical metastasis from squamous cell carcinoma of the maxillary alveolus and hard palate.
- Squamous cell carcinoma of the parotid Gland.
- Safety of uvulopalatopharyngoplasty as outpatient surgery.
- Current use of 18F-fluorodeoxyglucose positron emission tomography and combined positron emission tomography and computed tomography in squamous cell carcinoma of the ...
- Consortium of otolaryngology-Head and neck surgery journals to collaborate in maintenance of high ethical standards.
- Head and neck malignancy: is PET/CT more accurate than PET or CT alone?
- Consortium of otolaryngology--Head and neck surgery journals to collaborate in maintenance of high ethical standards.
Schools
Upstate Medical University College of Health Professions
Mc Va
SUNY Syracuse
Procedures Preformed
- Excision of Parotid, Sublingual, or Submandibular Gland
- Excision or Destruction of Pharynx Lesion
- Glossectomy
- Laryngectomy and Pharyngectomy
- View All
Conditions Treated
- Chronic Laryngitis
- Deafness
- Dysphagia
- Ear Ache
- View All
Doctors Specialties
- Ear, Nose, and Throat
- Otolaryngology (ENT)
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- Pittsburgh Magazine
- Fellow (FAAO-HNS)
- Fellow (FACS)
- Top MD
Education
-
SUNY Upstate Medical University -
Virginia Commonwealth University Health System -
State University of New York Upstate Medical University
Hospital
-
UPMC Presbyterian Shadyside
Drug Facts
| NPI NUMBER | 1942274303 | |
| NPPES Provider LastName | JOHNSON | |
| NPPES Provider FirstName | JONAS | |
| NPPES Provider ZIPCode | 152132546 | |
| NPPES Provider State | PA | |
| Specialty Description | Otolaryngology | |
| Total Claim Count | 195.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1942274303 |
| Last Name Of The Provider | JOHNSON |
| First Name Of The Provider | JONAS |
| View All |
Similar Doctors
|
|
Dr. Philip A. Pollice, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew B. Straka, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shelly J. McQuone, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sandeep Kathju, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Seungwon Kim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Umamaheswar Duvvuri, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth H. Toh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vyvy N. Young, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William G. Albergotti III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Summit B. Kundaria, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nivedita Sahu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amanda L. Stapleton, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adrienne W. Wong, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Noel Jabbour, MD
This Doctor is OpenDoctor Recommended.
|